Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Trademark Information
Application ID
Status
Sub Status
Date of Application
25 August 1999
Classes
5
Proprietor
6/14, Kirti Nagar Industrial Area, New Delhi 110 015.
Attorney
Devanshu Jain[17750]
95 A, Bk I, Shalimar Bagh, Delhi 110088.
Type
Word
State
Chandigarh
Country
Filing Mode
Branch Office
IP Office
DELHI
Used Since
01 December 1998
Valid / Upto
25 August 2026
Description
[Class : 5] Medicinal And Pharmaceuticals Preaprtions And All Including In Class 5.
PR Details
. Registration Renewed For A Period Of 10 Years From 25 Th August, 2006 Advertised In Journal No.1353
Registration Renewed For A Period Of 10 Years From 25/08/2016 Advertised In Journal No. 1749
Pursuant To A Request On Form Tm 50 Dated 28/04/2016 And Order Thereon Dated 19/09/2016 The Address For Service Is Altered To Devanshu Jain , 95 A, Bk I, Shalimar Bagh, Delhi 110088.
Pursuant To A Request On Form Tm P Dated 27/03/2021 And Order Thereon Dated 27/03/2021 Registered Proprietor's Name/Trading Style Is Altered To Arbro Pharmaceuticals Private Limited.
Sign In to Follow Application
All Documents & Correspondence
All Documents & Correspondence
Uploaded Documents
| 1 | Additional Representation Sheet | 25 Aug 1999 |
| 1 | Examination Report | 25 Aug 1999 |
| 2 | Additional Representation Sheet | 25 Aug 1999 |
| 2 | Certificate | 25 Aug 1999 |
| 3 | Examination Report | 25 Aug 1999 |
| 3 | Certificate | 25 Aug 1999 |
| 4 | Other Documents | 25 Aug 1999 |
| 4 | Note Sheet | 25 Aug 1999 |
| 5 | Other Documents | 25 Aug 1999 |
| 5 | TM-1 | 25 Aug 1999 |
| 6 | Note Sheet | 25 Aug 1999 |
| 6 | TM-1 | 25 Aug 1999 |
| 7 | TM-12 | 28 Apr 2016 |
| 7 | TM-50 | 28 Apr 2016 |
| 8 | TM-12 | 28 Apr 2016 |
| 8 | TM-50 | 28 Apr 2016 |
| 9 | Grounds of Opposition | 23 Dec 2016 |
| 10 | Authorization Document (POA) | 23 Dec 2016 |
| 11 | TM-P(CHANGE NAME OF REGISTERED PROP/USER) | 27 Mar 2021 |
| 12 | TM-M(CERTIFICATIE OF REGISTER (U/S 137) / CERTIFIED COPY OF A DOCUMENT) | 27 Mar 2021 |